Citicoline as Neuroprotector in Preterm

Phase 3RecruitingNCT03966170

Sherief Abd-Elsalam40 enrolled

Overview

Citicoline as neuroprotector in preterm

Efficacy of Citicoline as neuroprotector in preterm; A randomized controlled trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Citicoline as neuroprotector

placebo drug

Sex: ALLMax age: 1 Month

Medical Language ↔ Plain English

Inclusion Criteria: * Preterm on CPAP or ventilator Exclusion Criteria: * Multiple congenital anomalies

Sherief Abd-Elsalam

Tanta, Egypt

RECRUITING

Number of children with affection of the brain

Time frame: 6 months

Sherief Abd-Elsalam, ass. prof.

CONTACT

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.